1 | 12-Lead ECG | - | - | - | - | [2] 140 140, 144 |
2 | ATALUREN | [1] Ataluren Ataluren | [1] D09323
D09323
| - | - | [6] 19 19, 113, 140, 246, 299, 329 |
3 | Cannabidiol | [1] Cannabidiol Cannabidiol | [1] D10915
D10915
| [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [18] 6 6, 8, 13, 36, 46, 95, 96, 97, 140, 144, 145, 156, 157, 158, 193, 206, 226, 271 |
4 | Cannabidiol (CBD) | [1] Cannabidiol Cannabidiol | [1] D10915
D10915
| [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [7] 6 6, 13, 140, 144, 145, 156, 158 |
5 | Cannabidiol Oral Solution | [1] Cannabidiol Cannabidiol | [1] D10915
D10915
| [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [4] 140 140, 144, 145, 193 |
6 | Carbidopa | [1] Carbidopa Carbidopa | [1] D00558
D00558
| [1] DDC DDC 💬 | [9] Alcoholism Alcoholism, Amphetamine addiction, Cocaine addiction, Dopaminergic synapse, Metabolic pathways, Phenylalanine metabolism, Serotonergic synapse, Tryptophan metabolism, Tyrosine metabolism 💬 | [9] 2 2, 4, 6, 13, 17, 90, 140, 164, 201 |
7 | CBD | - | - | - | - | [12] 2 2, 6, 8, 13, 36, 46, 140, 144, 145, 156, 158, 206 |
8 | CBD - Oral Solution, is known as Epidiolex, and is the approved name in the USA. | [1] Cannabidiol Cannabidiol | [1] D10915
D10915
| [2] CNR1 CNR1, CNR2 💬 | [4] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction, Rap1 signaling pathway, Retrograde endocannabinoid signaling, Thermogenesis 💬 | [2] 140 140, 144 |
9 | Clemizole | [1] Clemizole Clemizole | - | - | - | [1] 140 140 |
10 | Clobazam | [1] Clobazam Clobazam | [1] D01253
D01253
| [16] GABRA1 GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ 💬 | [7] GABAergic synapse GABAergic synapse, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction 💬 | [2] 140 140, 144 |
11 | DIACOMIT | [1] Stiripentol Stiripentol | [1] D05928
D05928
| - | - | [1] 140 140 |
12 | DIACOMIT (Stiripentol) | [1] Stiripentol Stiripentol | [1] D05928
D05928
| - | - | [1] 140 140 |
13 | EPX-100 (Clemizole HCl) | [1] Clemizole Clemizole | - | - | - | [1] 140 140 |
14 | EPX-100 (Clemizole Hydrochloride) | [1] Clemizole Clemizole | - | - | - | [1] 140 140 |
15 | Fenfluramina | [1] Fenfluramine Fenfluramine | [1] D07945
D07945
| [4] HTR2A HTR2A, HTR2B, HTR2C, SLC6A4 💬 | [6] Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | [2] 140 140, 144 |
16 | Fenfluramina Cloridrato | [1] Fenfluramine Fenfluramine | [1] D07945
D07945
| [4] HTR2A HTR2A, HTR2B, HTR2C, SLC6A4 💬 | [6] Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | [2] 140 140, 144 |
17 | FENFLURAMINE | [1] Fenfluramine Fenfluramine | [1] D07945
D07945
| [4] HTR2A HTR2A, HTR2B, HTR2C, SLC6A4 💬 | [6] Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | [4] 140 140, 144, 145, 149 |
18 | FENFLURAMINE HYDROCHLORIDE | [1] Fenfluramine Fenfluramine | [1] D07945
D07945
| [4] HTR2A HTR2A, HTR2B, HTR2C, SLC6A4 💬 | [6] Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | [2] 140 140, 144 |
19 | FENFLURAMINE HYDROCHLORIDE (colorless) | [1] Fenfluramine Fenfluramine | [1] D07945
D07945
| [4] HTR2A HTR2A, HTR2B, HTR2C, SLC6A4 💬 | [6] Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | [2] 140 140, 144 |
20 | FENFLURAMINE HYDROCHLORIDE (red) | [1] Fenfluramine Fenfluramine | [1] D07945
D07945
| [4] HTR2A HTR2A, HTR2B, HTR2C, SLC6A4 💬 | [6] Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | [1] 140 140 |
21 | Frisium | - | - | - | - | [1] 140 140 |
22 | FRISIUM*30CPS 10MG | - | - | - | - | [1] 140 140 |
23 | GWP42003-P | - | - | - | - | [5] 140 140, 144, 145, 156, 158 |
24 | GWP42003-P 10 mg/kg/day Dose | - | - | - | - | [1] 140 140 |
25 | GWP42003-P 20 mg/kg/day Dose | - | - | - | - | [2] 140 140, 144 |
26 | GWP42003-P 5 mg/kg/day Dose | - | - | - | - | [1] 140 140 |
27 | Levodopa | [1] Levodopa Levodopa | [1] D00059
D00059
| [5] DRD1 DRD1, DRD2, DRD3, DRD4, DRD5 💬 | [11] Alcoholism Alcoholism, Amphetamine addiction, Calcium signaling pathway, Cocaine addiction, Dopaminergic synapse, Gap junction, Morphine addiction, Neuroactive ligand-receptor interaction, Parkinson disease, Rap1 signaling pathway, cAMP signaling pathway 💬 | [8] 2 2, 4, 6, 17, 90, 140, 164, 201 |
28 | Lorcaserin | [1] Lorcaserin Lorcaserin | - | - | - | [1] 140 140 |
29 | ME2080 (stiripentol) | [1] Stiripentol Stiripentol | [1] D05928
D05928
| - | - | [1] 140 140 |
30 | None | - | - | - | - | [16] 6 6, 46, 51, 65, 78, 84, 85, 96, 97, 140, 160, 161, 171, 231, 271, 299 |
31 | None at this time | [1] Interleukin-1 alpha, human recombinant Interleukin-1 alpha, human recombinant | - | - | - | [2] 96 96, 140 |
32 | Other antiepileptics | - | - | - | - | [1] 140 140 |
33 | PEG | - | - | - | - | [12] 6 6, 13, 41, 46, 65, 78, 96, 97, 140, 144, 240, 299 |
34 | Placebo | - | - | - | - | [27] 3 3, 5, 6, 13, 14, 37, 40, 46, 49, 50, 51, 53, 63, 66, 67, 79, 85, 86, 88, 96, 97, 140, 144, 149, 226, 271, 276 |
35 | SOTICLESTAT | - | - | - | - | [2] 140 140, 144 |
36 | Stiripentol | [1] Stiripentol Stiripentol | [1] D05928
D05928
| - | - | [1] 140 140 |
37 | Stiripentolo | - | - | - | - | [1] 140 140 |
38 | STK-001 | - | - | - | - | [1] 140 140 |
39 | STK-001 - Multiple Ascending Doses | - | - | - | - | [1] 140 140 |
40 | STK-001 - Single Ascending Doses | - | - | - | - | [1] 140 140 |
41 | TAK-935 | - | - | - | - | [2] 140 140, 144 |
42 | TOPAMAX | [1] Topiramate Topiramate | [1] D00537
D00537
| [36] CA2 CA2, CA4, CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [53] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Arrhythmogenic right ventricular cardiomyopathy, Bile secretion, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [1] 140 140 |
43 | TOPIRAMATE | [1] Topiramate Topiramate | [1] D00537
D00537
| [36] CA2 CA2, CA4, CACNA1C, CACNA1D, CACNA1F, CACNA1S, GABRA1, GABRA2, GABRA3, GABRA4, GABRA5, GABRA6, GABRB1, GABRB2, GABRB3, GABRD, GABRE, GABRG1, GABRG2, GABRG3, GABRP, GABRQ, GRIA1, GRIA2, GRIA3, GRIA4, GRIK1, GRIK2, GRIK3, GRIK4, GRIK5, SCN1A, SCN2A, SCN3A, SCN5A, SCN9A 💬 | [53] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Arrhythmogenic right ventricular cardiomyopathy, Bile secretion, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cocaine addiction, Collecting duct acid secretion, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Gastric acid secretion, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Huntington disease, Hypertrophic cardiomyopathy, Insulin secretion, Long-term depression, Long-term potentiation, MAPK signaling pathway, Metabolic pathways, Morphine addiction, Neuroactive ligand-receptor interaction, Nicotine addiction, Nitrogen metabolism, Oxytocin signaling pathway, Pancreatic secretion, Pathways of neurodegeneration - multiple diseases, Prion disease, Proximal tubule bicarbonate reclamation, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Spinocerebellar ataxia, Taste transduction, Tight junction, Transcriptional misregulation in cancer, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [6] 6 6, 97, 140, 144, 156, 193 |
44 | Turmeric | [1] Turmeric Turmeric | - | - | - | [4] 140 140, 144, 158, 299 |
45 | Verapamil | [1] Verapamil Verapamil | [2] D00619
D00619
,
D02356
| [4] CACNA1C CACNA1C, CACNA1D, CACNA1F, CACNA1S 💬 | [37] Adrenergic signaling in cardiomyocytes Adrenergic signaling in cardiomyocytes, Aldosterone synthesis and secretion, Alzheimer disease, Amphetamine addiction, Arrhythmogenic right ventricular cardiomyopathy, Calcium signaling pathway, Carbohydrate digestion and absorption, Cardiac muscle contraction, Cellular senescence, Chemical carcinogenesis - receptor activation, Cholinergic synapse, Circadian entrainment, Cortisol synthesis and secretion, Cushing syndrome, Dilated cardiomyopathy, Dopaminergic synapse, GABAergic synapse, Glutamatergic synapse, GnRH secretion, GnRH signaling pathway, Growth hormone synthesis, secretion and action, Hypertrophic cardiomyopathy, Insulin secretion, Long-term potentiation, MAPK signaling pathway, Oxytocin signaling pathway, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, Retrograde endocannabinoid signaling, Serotonergic synapse, Taste transduction, Tight junction, Type II diabetes mellitus, Vascular smooth muscle contraction, cAMP signaling pathway, cGMP-PKG signaling pathway 💬 | [3] 96 96, 140, 167 |
46 | ZX008 | - | - | - | - | [2] 140 140, 144 |
47 | ZX008 (Fenfluramine Hydrochloride) | [1] Fenfluramine Fenfluramine | [1] D07945
D07945
| [4] HTR2A HTR2A, HTR2B, HTR2C, SLC6A4 💬 | [6] Calcium signaling pathway Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand-receptor interaction, Serotonergic synapse, Synaptic vesicle cycle 💬 | [2] 140 140, 144 |
48 | ZX008 - 0.2 mg/kg/day | - | - | - | - | [1] 140 140 |
49 | ZX008 - 0.4 mg/kg/day | - | - | - | - | [1] 140 140 |
50 | ZX008 - 0.8 mg/kg/day | - | - | - | - | [1] 140 140 |
51 | ZX008 - 20 mg/day maximum dose | - | - | - | - | [1] 140 140 |
52 | ZX008 0.2 to 0.8 mg/kg/day | - | - | - | - | [2] 140 140, 144 |